CDK3 and neuroblastoma: Other anti-NB strategies are the use of phosphoinositide 3-kinase, fibroblast growth factor receptor, or cyclin-dependent kinase 3/6 inhibitors [2]; immunotherapy [3,4]; NB-extracellular vesicles targeting [5]; natural killer cells [6,7]; and retinoic acid therapy [8].